EUVIMEDEUVIMED entdecken
LeitlinieStudienprotokoll

Belgian protocol for indication and selection of patients with unresectable colorectal cancer liver metastases eligible for liver transplantation

G Rasschaert, M Vandermeulen, M Van den Eynde, H Eker, T Vandamme, B Bracke, X Verhelst, J Verbeek, H Van Vlierberghe, H Topal, V Labille, D Monbaliu und 14 weitere

Acta Gastro-Enterologica Belgica · 2026

DOI: 10.51821/89.3.14956 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Acta Gastro-Enterologica Belgica, 2026. Verfasst von G Rasschaert und 25 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Oncology Department, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Liver Transplantation, Patient Selection.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Colorectal cancer (CRC) is common in Western countries, about 50% of patients develop liver metastases (CLM). While local CLM therapies can achieve 5-year survival up to 60%, most patients eventually become unresectable (uCLM) and have poor outcomes with systemic treatment alone. Prospective studies, including SECA I and II and the TransMet trial, showed that in carefully selected patients, liver transplantation (LTx) can achieve survival outcomes comparable to standard LTx indications. The aim of this work was to develop a harmonized national consensus protocol for the indication and selection of uCLM patients eligible for LTx. Patients and methods Under the coordination of the Belgian Liver & Intestine Advisory Committee (Be-LIAC), all six Belgian transplant centers delegated a transplant surgeon, an oncologist and an hepatologist to a working group that performed a literature review and drafted preliminary criteria. Three successive national meetings and a structured voting refined these criteria in the current protocol.

Results

Consensus was reached on inclusion and exclusion criteria for LTx in uCLM. Two key conditions are liver-only disease and technically uCLM. Strict requirements include a six months disease stability or response on systemic therapy and an obligatory eight-week treatment holiday. Absolute CEA levels and specific somatic mutations are not excluded. A national Be-LIAC governance model was established, combining local prospective decision-making with central auditing and registry-based evaluation.

Conclusions

A harmonized national protocol for LTx inuCLM has been established, ensuring consistent patient selection across all Belgian centers. Stricter criteria and a national governance model aim to optimize outcomes while maintaining ethical allocation of donor organs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsLiver TransplantationPatient SelectionHumansBelgiumClinical Protocols

Stichwörter der Autor:innen

LTxnational consensusselectionuCLM

Autor:innen und Institutionen

  • Gastrointestinal Oncology Department, University Hospitals Leuven, Leuven, Belgium.
  • Abdominal and Transplant Surgery Department, University Hospital Liège, Liège, Belgium.
  • Oncology Department, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • General and Hepatopancreatobiliary Surgery Department, University Hospital Gent, Gent, Belgium.
  • Oncology Department, University Hospital Antwerpen, Antwerpen, Belgium.
  • Hepatopancreatobiliary and Transplant Surgery Department, University Hospital Antwerpen, Antwerpen, Belgium.

Zitieren

APA

Rasschaert, G., Vandermeulen, M., Van den Eynde, M., Eker, H., Vandamme, T., Bracke, B., Verhelst, X., Verbeek, J., Van Vlierberghe, H., Topal, H., Labille, V., Monbaliu, D., Op de Beeck, B., Gustot, T., Sainz Barriga, M., Sclafani, F., Vandecaveye, V., Vanwolleghem, T., Amicone, C., …, & Coubeau, L. (2026). Belgian protocol for indication and selection of patients with unresectable colorectal cancer liver metastases eligible for liver transplantation. Acta Gastro-Enterologica Belgica. https://doi.org/10.51821/89.3.14956

Vancouver

Rasschaert G, Vandermeulen M, Van den Eynde M, Eker H, Vandamme T, Bracke B, et al. Belgian protocol for indication and selection of patients with unresectable colorectal cancer liver metastases eligible for liver transplantation. Acta Gastro-Enterologica Belgica. 2026. doi:10.51821/89.3.14956

BibTeX
@article{Rasschaert2026,
  author = {Rasschaert, G and Vandermeulen, M and Van den Eynde, M and Eker, H and Vandamme, T and Bracke, B and Verhelst, X and Verbeek, J and Van Vlierberghe, H and Topal, H and Labille, V and Monbaliu, D and Op de Beeck, B and Gustot, T and Sainz Barriga, M and Sclafani, F and Vandecaveye, V and Vanwolleghem, T and Amicone, C and Lucidi, V and Verslype, C and Geboes, K and Dahlqvist, G and Pirenne, J and Detry, O and Coubeau, L},
  title = {Belgian protocol for indication and selection of patients with unresectable colorectal cancer liver metastases eligible for liver transplantation},
  journal = {Acta Gastro-Enterologica Belgica},
  year = {2026},
  doi = {10.51821/89.3.14956}
}
Kostenlos starten →